ArticleThe Journal of clinical and aesthetic dermatology2026

Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.

Sergio Santos-Alarcón et al.PubMed ↗Full text ↗

No numbers read from the abstract.